Stimulate the brain
reduce seizures
Epicranial Application of Stimulation Electrodes for Epilepsy

About EASEE®

Medication alone often doesn't help!

The most common treatment method for epilepsy is medication. However, there are many individuals with epilepsy who don't benefit sufficiently from antiepileptic drugs. If further epileptic events occur despite treatment with two antiepileptic drugs effective for the respective seizure or epilepsy type, it is referred to as "medically refractory epilepsy.".

Click here, if you want to read medical information about EASEE® as a healthcare professional. Are you interested in EASEE® as an affected individual? Then click here

Where is EASEE® implanted

Centres of Excellence

Keyvisual EASEE®

The EASEE® System is suitable for individuals with focal epilepsies. Since September 15, 2022, the EASEE® System is CE certified for adults with therapy-resistant focal epilepsies.

The following epilepsy centers have experience with EASEE® or are familiar with data from clinical studies. You can inquire there to determine if EASEE® could be a potential option for you. Children and adolescents can participate in a study that started in July 2023.

Specialists near you

Registration for our Newsletter
News about epilepsy for healthcare professionals directly to inbox
Thank you for your interest in our newsletter
We sent you an email to verify your address. Please open the email and click the link to receive our newsletter
We look forward to keeping you informed at regular intervals
Yes, I'm interested in EASEE® and would like to receive information about it via email. I can withdraw my consent at any time with effect for the future.

The company behind EASEE®

Precisis GmbH

Precisis GmbH, based in Heidelberg, specializes in the development of innovative medical devices and is known for its outstanding successes in the field of device-guided brain therapies.

Production EASEE® Osypka

About the Company

The Precisis team develops novel bioelectronic treatment methods that involve directing therapeutic currents into specific target areas of the brain. Depending on the individual situation of the patients, this can activate or inhibit certain brain cells.

About Precisis
We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience with it. For more information about how we use your data, please see our privacy policy.